Thromboembolic and bleeding complications following primary total knee arthroplasty : a Danish nationwide cohort study.

Astrid Blicher ScheldeJanne PetersenThomas Bo JensenKirill GromovSøren OvergaardJonas Bjerring OlesenEspen Jimenez-Solem

Published in: The bone & joint journal (2021)

Treatment with dalteparin or dabigatran was associated with a decreased 90-day risk of VTE following primary TKA surgery compared with treatment with rivaroxaban. Cite this article: Bone Joint J 2021;103-B(10):1571-1577.

Keyphrases

total knee arthroplasty
atrial fibrillation
venous thromboembolism
minimally invasive
risk factors
pulmonary embolism
combination therapy
body composition
soft tissue